2025-08-14 - Analysis Report
Okay, here's the report on TG Therapeutics Inc (TGTX), incorporating the provided data and analysis requests.

**Report on TG Therapeutics Inc (TGTX)**

**0. Executive Summary**

TGTX is currently underperforming the S&P 500. Recent volatility, coupled with concerning moving average trends and concerning technical indicators warrants caution.  While recent earnings have shown positive EPS, long term prospects for the stock are not positive. The company has made headlines recently for both regulatory changes and general volatility.

**1. Relative Performance Analysis**

*   **Ticker:** TGTX
*   **Company:** TG Therapeutics Inc
*   **Description:** TG Therapeutics Inc. is a biopharmaceutical company focused on the development and commercialization of novel treatments for B-cell malignancies and autoimmune diseases.

    *누적수익률(Accumulated Return)*
*   **TGTX Accumulated Return:** 55.74%
*   **S&P 500 (VOO) Accumulated Return:** 86.23%
*   **Disparity (최근):** -37.7
*   **Relative Disparity:** 11.4

    *Relative Disparity (상대이격도)*: 11.4 indicates that TGTX's performance relative to VOO is near the lower end of its historical range. The stock is severely underperforming.

*   **Alpha, Beta Analysis:**

| Year       | CAGR     | MDD   | Alpha    | Beta  | Cap(B) |
| ---------- | -------- | ----- | -------- | ----- | ------ |
| 2015-2017  | -2.0%    | 2.0%  | -4.0%    | -1.4  | 1.3    |
| 2016-2018  | -54.0%   | 58.7% | -50.0%   | -0.0  | 0.7    |
| 2017-2019  | 32.0%    | 58.7% | 10.0%    | -0.0  | 1.8    |
| 2018-2020  | 424.0%   | 58.7% | 397.0%   | -0.0  | 8.2    |
| 2019-2021  | 132.0%   | 63.5% | 83.0%    | -0.0  | 3.0    |
| 2020-2022  | -84.0%   | 70.4% | -91.0%   | 0.0   | 1.9    |
| 2021-2023  | -380.0%  | 70.4% | -400.0%  | -0.7  | 2.7    |
| 2022-2024  | 72.0%    | 73.1% | 45.0%    | -0.8  | 4.8    |
| 2023-2025  | 57.0%    | 73.1% | 6.0%     | -0.0  | 4.4    |

*   **Analysis:**
    *   **CAGR:** Fluctuates wildly, indicating inconsistent growth.
    *   **MDD:** High Maximum Drawdown values suggest significant risk.
    *   **Alpha:**  Generally negative, meaning TGTX has underperformed its benchmark. There are outliers.
    *   **Beta:**  Generally close to zero, suggesting TGTX's price is largely independent of the market.

**2. Recent Stock Price Movement**

*   **Current Price:** 27.87
*   **Previous Close:** 27.12
*   **Change:** 2.77%
*   **5-Day Moving Average:** 27.196
*   **20-Day Moving Average:** 33.0915
*   **60-Day Moving Average:** 35.5018

*   **Analysis:** The price is below both the 20-day and 60-day moving averages, indicating a downtrend. The recent price increase is a positive signal, but the trend indicates selling pressure on the stock.

**3. Technical Indicators**

*   **Market Risk Indicator (MRI):** 0.3234 (Low Risk)
*   **RSI:** 20.38 (Oversold)
*   **PPO:** -2.3906
*   **Hybrid Signal:** cash_66%_Sell 5.6% of holdings (122 shares - Caution - MRI:0.34)
*   **Delta_Previous_Relative_Divergence:** -3.5 (Negative: Short-term Decline)
*   **Expected Return (%):** -268.0%

*   **Analysis:**
    *   **MRI:** Indicates Low risk in the market
    *   **RSI:** The RSI indicates the stock is oversold and might be due for a bounce, although oversold conditions can persist.
    *   **PPO:** Indicates the stock is underperforming (negative).
    *   **Hybrid Signal:** Suggests a strong sell rating.
    *   **Delta_Previous_Relative_Divergence:** The negative change in relative disparity suggests continued short-term underperformance.
    *   **Expected Return:** The negative expected return signals significant long-term underperformance compared to the S&P 500.

The price change is a sharp uptick in the stock. The rest of the indicators are showing the opposite so there is a potential that the stock is either recovering or undergoing a speculative bubble.

**4. Recent News & Significant Events**

*   **2025-08-14:** Major business developments, regulatory changes, or market events.
*   **2025-08-12:** Analyst discussions regarding recent performance and outlook.
*   **2025-08-11:** Notable stock volatility.
*   **2025-08-10:** Market experts highlight risks and opportunities.

*   **Analysis:** The news items indicate a period of significant activity and scrutiny for TGTX, including volatility, analyst attention, and potential business changes. The exact nature of these events requires further investigation.

**5. Recent Earnings Analysis**

| 날짜       | EPS  | 매출     |
| ---------- | ---- | -------- |
| 2025-08-08 | 0.19 | 0.14 B$ |
| 2025-05-09 | 0.03 | 0.12 B$ |
| 2024-11-07 | 0.03 | 0.08 B$ |
| 2024-08-09 | 0.05 | 0.07 B$ |
| 2025-08-08 | 0.05 | 0.07 B$ |

*   **Analysis:** The company is showing increasing EPS numbers. Revenue is increasing as well. This is a positive sign.

**6. Financial Information**

**Revenue and Profitability:**

| Quarter    | Revenue | Profit Margin |
| ---------- | ------- | ------------- |
| 2025-06-30 | $0.14B  | 86.58%        |
| 2025-03-31 | $0.12B  | 87.14%        |
| 2024-12-31 | $0.11B  | 85.77%        |
| 2024-09-30 | $0.08B  | 88.86%        |
| 2024-06-30 | $0.07B  | 88.70%        |

**Capital and Profitability:**

| Quarter    | Equity  | ROE     |
| ---------- | ------- | ------- |
| 2025-06-30 | $0.28B  | 10.20%  |
| 2025-03-31 | $0.24B  | 2.13%   |
| 2024-12-31 | $0.22B  | 10.49%  |
| 2024-09-30 | $0.19B  | 2.02%   |
| 2024-06-30 | $0.18B  | 3.87%   |

*   **Analysis:**
    *   **Revenue and Profitability:** Revenue is trending upward, and profit margins are consistently high, suggesting strong operational efficiency.
    *   **Capital and Profitability:** Equity is increasing, but ROE fluctuates significantly, indicating inconsistent returns on equity.

**7. 종합 Analysis and Recommendations**

TGTX exhibits a mixed picture. While recent earnings and financials show positive trends in revenue, profit margins, and EPS, the stock's technical indicators (RSI, PPO), historical underperformance relative to the S&P 500, and negative expected return raise concerns.

**Recommendation:**
*   Given the volatility and underperformance, a **sell** or **hold** strategy is advisable.
*   Monitor upcoming news and earnings announcements closely to reassess the company's trajectory.
*   The recent price increase should be noted, but should be considered as speculation without more supporting evidence.

